Anti-Cancer Clinical Compound Library

Description: - A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);- Bioactivity confirmed by pre-clinical research and all of them are currently in clinical trial phases, representing the cutting-edge treatments for cancers;- Effective tool for cancer research and drug repurposing screening;- Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc., in lung cancer, breast cancer, leukemia, lymphoma, etc.- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- Structurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;

• Artikelnummer: TGML2120-50uL
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: L2120-50uL
• Verpackungseinheit: 50 μL
• Mengeneinheit: STK